Differences in outcomes between oral anticoagulation “new starters” and “switchers” in patients with nonvalvular atrial fibrillation: A pooled analysis of the AMADEUS and BOREALIS trials — Ying Bai (2019) | RDL Network
Differences in outcomes between oral anticoagulation “new starters” and “switchers” in patients with nonvalvular atrial fibrillation: A pooled analysis of the AMADEUS and BOREALIS trials
In this post hoc analysis of clinical trial patients with AF, "new starters" and "switchers" for VKA initiation had nonstatistically significant rates of trial-adjudicated thromboembolism, major bleeding, and all-cause mortality.
Giulio Francesco Romiti, Bernadette Corica, Tommaso Bucci, Giuseppe Boriani, Brian Olshansky, Tze‐Fan Chao, Menno V. Huisman, Marco Proietti, Professor Gregory Lip
Laila Stærk, Emil Loldrup Fosbøl, Morten Lamberts, Anders Nissen Bonde, Kasper Gadsbøll, Caroline Sindet‐Pedersen, Ellen Holm, Thomas Alexander Gerds, Brice Ozenne, Professor Gregory Lip, Christian Torp‐Pedersen, Gunnar Gislason, Jonas Bjerring Olesen
Discussion(0)
No comments yet. Be the first to comment.